A study to discover novel pharmaceutical cocrystals of pelubiprofen with a machine learning approach compared

Pelubiprofen (PF), a biopharmaceutical classification system (BCS) class II non-steroidal anti-inflammatory drug, has been on the market only in its crystalline form. To discover the first cocrystal form(s) of the drug, artificial neural network (ANN) modeling and the p K a rule were adopted to pred...

Full description

Saved in:
Bibliographic Details
Published in:CrystEngComm 2022-05, Vol.24 (21), p.3938-3952
Main Authors: Kim, Paul, Lee, In-Seo, Kim, Ji-Yoon, Mswahili, Medard E, Jeong, Young-Seob, Yoon, Woo-Jin, Yun, Ho-Seop, Lee, Min-Jeong, Choi, Guang J
Format: Article
Language:English
Subjects:
Artificial neural networks
Crystallization
Crystals
Machine learning
Nicotinamide
Pharmaceuticals
Single crystals
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pelubiprofen (PF), a biopharmaceutical classification system (BCS) class II non-steroidal anti-inflammatory drug, has been on the market only in its crystalline form. To discover the first cocrystal form(s) of the drug, artificial neural network (ANN) modeling and the p K a rule were adopted to predict the most probable coformers that could form cocrystals with PF. Among candidate molecules examined theoretically and experimentally, isonicotinamide (INA) and nicotinamide (NCA) formed PF-based cocrystals through evaporative crystallization. The structures of the PF-INA and PF-NCA cocrystals were verified through multiple characterization techniques, including single-crystal X-ray diffraction. These two cocrystals demonstrated remarkably better water solubility and dissolution behaviors than did pure PF in both acidic and neutral solutions. Even with deficiency in the prediction capability, the combination of machine learning-based and knowledge-based coformer screening and the subsequent synthetic experiments would be a potential approach for discovering novel pharmaceutical cocrystals in the future. Pharmaceutical cocrystals of pelubiprofen (PF) were discovered for the first time. 16 candidates to form cocrystals with PF were selected via the ANN model and the p K a rule.
ISSN:1466-8033
1466-8033
DOI:10.1039/d2ce00153e